Data Science Conference

Bridging Data Science and Clinical Development!

Back to Agenda

Session 8: Closing Plenary - Data and Technology Strategy

Session Chair(s)

Pritibha Singh, MBA, MSc

Senior Manager, Corporate Affairs Analytics & Insights

Novartis AG, Switzerland

Advances in data science, artificial intelligence (AI) and machine learning (ML) are transforming the healthcare, pharmaceutical, and regulatory industries. In this session we will discuss the regulatory developments, challenges, opportunities and future perspectives on data science, AI and ML.

Learning Objective : At the conclusion of this session, participants should be able to:
Discuss regulatory developments in data science, AI and ML

Identify regulatory challenges and opportunities with data science, AI and ML
Illustrate the future regulatory perspectives on data science, AI and ML

Speaker(s)

Speaker

Ram Iyer, MS

FDA, United States

Chief Data Officer

Have an account?